Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 3, Issue 4, 2007, Pages 246-257

  Yadav, Awesh Kumar ^a   Mishra, Pradeep ^a   Mishra, Anil K ^b   Mishra, Pushpa ^b   Jain, Sanyog ^b   Agrawal, Govind Prasad ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Doxorubicin; Hyaluronic acid; Nanoparticles; Tumor Targeting

Indexed keywords

DOXORUBICIN (DOX); HEMOLYTIC TOXICITY; SUBACUTE TOXICITY;

COPOLYMERS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTIMIZATION; POLYETHYLENE GLYCOLS;

NANOPARTICLES;

DIAMINE; DOXORUBICIN; DRUG CARRIER; HYALURONIC ACID; MACROGOL; MONOMETHOXY(POLYETHYLENE GLYCOL); NANOPARTICLE; POLYGLACTIN; POLYMER; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DIALYSIS MEMBRANE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG STRUCTURE; EHRLICH ASCITES TUMOR; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PH; RAT; SUSTAINED DRUG RELEASE; TISSUE DISTRIBUTION; TOXICITY TESTING; TUMOR VOLUME; X RAY DIFFRACTION;

ANIMALS; CARCINOMA, EHRLICH TUMOR; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; DOXORUBICIN; DRUG CARRIERS; HYALURONIC ACID; IMMUNOGLOBULIN G; LACTIC ACID; MATERIALS TESTING; MELPHALAN; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; TISSUE DISTRIBUTION;

MUS;

EID: 36749030021     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2007.09.004     Document Type: Article

References (32)

1. Zhang J.Y. Apoptosis-based anticancer drugs. Nat Rev Drug Discovery 1 (2002) 101-102
2. Kim G.J., and Nie S. Targeted cancer nanotherapy. Nanotoday (2005) 28-33
3. Allemann E., Gurny R., and Doelker E. Drug-loaded nanoparticles preparation method and drug targeting tissues. Eur J Pharm Biopharm 39 (1993) 173-191
4. Cavallaro G., Mariano L., Salmaso S., Caliceti P., and Gaetano G. Folate mediated targeting of polymeric conjugates of gemcitabine. Int J Pharm 307 (2006) 258-269
5. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surfaces B: Biointerfaces 18 (2000) 301-313
6. Shuai X., Ai H., Nasongkla N., Kim S., and Gao J. Micellar carriers based on block copolymers of poly (ε-caprolactone) and poly (ethylene glycol) for doxorubicin delivery. J Control Release. 98 (2004) 415-426
7. Kim S.Y., and Lee Y.M. Taxol-loaded block copolymer nanospheres composed of methoxy poly (ethylene glycol) and poly (ε-caprolactone) as novel anticancer drug carriers. Biomaterials 22 (2001) 1697-1704
8. Gref R., Couvreur P., Barratt G., and Mysiakine E. Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials 24 (2003) 4529-4537
9. Park E.K., Lee S.B., and Lee Y.M. Preparation and characterization of methoxy poly (ethylene glycol)/poly (ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 26 (2005) 1053-1061
10. Yun Y.H., Goetz D.J., Yellen P., and Chen W. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 25 (2004) 147-157
11. Asplund T., and Heldin P. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res 54 (1994) 4516-4523
12. Naor D., Nedvetzki S., Golan I., Melnik L., and Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci 39 (2002) 527-579
13. Wang C., Thor A.D., Moore D.H., Zhao Y., Kerschmann R., Stern R., et al. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signalling, correlates with over-expression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res 4 (1998) 567-576
14. Günthert U. CD44: a multitude of isoforms with diverse functions. Curr Topics Microbiol Immunol 184 (1993) 47-63
15. Culty M., Nguyen H.A., and Underhillm C.B. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 116 (1992) 1055-1062
16. Coradini D., Pellizzaro C., Miglierini G., Daidone M.G., and Perbellini A. Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line. Int J Cancer 81 (1999) 411-416
17. Luo Y., and Prestwich G.D. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem 10 (1999) 755-763
18. Zalipsky S., Gilon C., and Zilkha A. Attachment of drugs to polyethylene glycols. Eur J. Polym 19 (1983) 1177-1183
19. Beletsi A., Panagi Z., and Avgoustakis K. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. Int J Pharm 298 (2005) 233-241
20. Jeong Y.I., Cheon J.B., Kim S.H., Nah J.W., Lee Y.M., Sung Y.K., et al. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release 51 (1998) 169-178
21. Dong Y., and Feng S.S. Methoxy poly (ethylene glycol)-poly (lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25 (2004) 2843-2849
22. Paul M., Laatiris A., Fessi H., Dufeu B., Durand B., Deniau M., et al. Pentamidine-loaded poly (d,l-lactide) nanoparticles: adsorption and drug release. Drug Dev Res. 43 (1998) 98-104
23. Chorny M., Fishbein I., Danenberg H.D., and Golomb G. Lipophilic drug loaded nanospheres by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Control Release 83 (2002) 389-400
24. Cho H., Chung D., and Jeongho A. Poly (d,l-lactide-ran-ε-caprolactone)-poly(ethylene glycol)-poly(d,l lactide-ran-ε-caprolactone) as parenteral drug delivery systems. Biomaterials 25 (2004) 3733-3742
25. Luo Y., Kirker K.R., and Prestwich G.D. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release 69 (2000) 169-184
26. Ryu J.G., Jeong Y.I., Kim Y.H., Kim I.S., Kim D.H., and Kim S.H. Preparation of core-shell type nanoparticles of poly(ε-caprolactone) /poly(ethylene glycol)/poly(ε-caprolactone) triblock copolymers. Bull Korean Chem Soc 22 (2001) 467-475
27. Park K., Lee G.Y., Kim Y.S., Yu M., Park R.W., Kim I.S., et al. Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. J Control Release 114 (2006) 300-306
28. Shenoy D., Little S., Langer R., and Amiji M. Poly (ethylene oxide)-modified poly (β-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: Part 2. In vivo distribution and tumor localization studies. Pharm Res 22 (2005) 2101-2114
29. Zeng C., Toole B.P., Kinney S.D., Kuo J., and Stamenkovic I. Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 77 (1998) 396-401
30. Lesley J., Hascall V.C., Tammi M., and Hyman R. Hyaluronan binding by cell surface CD44. J Biol Chem 275 (2000) 267-269
31. Mo Y., and Lim L.Y. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Control Release 108 (2005) 244-262
32. Anghileri L.J. In vivo synthesis of acid mucopolysaccharides by Ehrlich ascites tumor cells. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 88 (1976) 17-24